Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÆóÀÇ ºñ¼Ò¼¼Æ÷¾Ï¿¡¼­ p53À¯ÀüÀÚ µ¹¿¬º¯ÀÌ¿Í TGF-¥â¿¡ °üÇÑ ºÐÀÚ»ý¹°ÇÐÀû ¿¬±¸ TGF-beta-1 Expression and p53 Mutation in Non-small Cell Carcinomas of the Lung

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 6È£ p.1022 ~ 1031
¼Ò¼Ó »ó¼¼Á¤º¸
±èÇÑ°â/Han Kyeom Kim ¹Ú¼³Èñ/³ª¿µ¼ø/°­¿ë±¸/±è¿µ½Ä/ÇÑÁ¤È£/¹Ú¹ÌÀÚ/±èÀμ±/Seol Hee Park/Young Soon Na/Yong Gu Kang/Young Sik Kim/Jung Ho Han/Mee Ja Park/Insun Kim

Abstract

°á·Ð
Æó¾ÏÁß ºñ¼Ò¼¼Æ÷¾Ï¿¡¼­´Â p53À¯ÀüÀÚ µ¹¿¬º¯ÀÌ°¡ 46% Á¤µµÀÇ ºóµµ·Î °üÂûµÇ¾ú°í TGF-¥â
-1 mRNA¹ßÇöÀ²ÀÌ ³ô¾Ò´Âµ¥ ÀÌ´Â 953 À¯ÀüÀÚ µ¹¿¬º¯ÀÌ¿¡ ÀÇÇØ ÇüÁú ÀüȯµÈ ¾Ï¼¼Æ÷°¡
TGF-¥â-1¿¡ ´ëÇÑ ¼¼Æ÷ Áõ½Ä ¾ïÁ¦ È¿°ú·ÎºÎÅÍ´Â ¹þ¾î³ªÁö¸¸ ÇÑÆíÀ¸·Î´Â TGF-¥â-1ÀÌ Á¾¾ç
°£ÁúÀÇ Ãàô ¹× Ç÷°ü ½Å»ýÀ» À¯µµÇϹǷΠ°á±¹Àº p53À¯ÀüÀÚ µ¹¿¬º¯ÀÌ¿Í TCF-¥â-1ÀÌ Á¾¾çÀÇ
¹ß»ý°ú Áõ½ÄÀ» À¯¹ßÇϴµ¥ ±â¿©ÇÑ´Ù°í »ý°¢µÈ´Ù. ±×·¯³ª ÀÌ·¯ÇÑ °¡¼³À» Áõ¸íÇÏ°í, p53°ú
TGF-¥â-1ÀÇ »óÈ£ °ü°è»Ó ¸¸ ¾Æ´Ï¶ó Æó¾ÏÀÇ ¹ß»ý°ú ÁøÇà°úÁ¤ÀÇ ¾î´À ´Ü°è¿¡ °ü¿©ÇÏ´Â Áö¸¦
¸íÈ®ÇÏ°Ô ¾Ë±â À§Çؼ­´Â ´õ ¸¹Àº ¿¬±¸°¡ ÀÌ·ç¾îÁ®¾ß ÇÏ°Ú´Ù
#ÃÊ·Ï#
Purpose : TGF-beta-1 is actually a major growth inhibitor for most cell types. We
assumed that the loss of TGF-beta-1 would be occurred during carcinogenesis of the
lung. Also, the mutation and expression of p53 have been known to be major molecular
change of non-small cell carcinoma of the lung. So, the relationship between the
mutation of p53 and the expression of TGF-beta-1 in the non-small cell carcinomas
were evaluated.
Materials and Methods : In 43 non-small cell carcinoma and normal tissue of the
lung, their TGF-beta-1 mRNA were measured by RT-PCR and p53 was studied by
SSCP and Western blotting assay.
Results : p53 mutation rate in non-small cell carcinomas of the lung (48.4%) was
much more frequent than the normal control group (14.3%). The expression rate of
TGF-beta-1 in lung carcinomas, especially squamous cell carcinoma (71.4%), was much
higher than the normal control group (42.9%). p53 mutation and TGF-beta-1 mRNA in
the lung carcinomas were not strongly correlated.
Conclusion : It suggests that high expression rate of TGF-beta-1 and p53 mutation
are associated with carcinogenesis of non-small cell carcinoma of the lung. High
expression rate of TGF-beta-1 in the lung carcinomas can be partly explained by the
fact that TGF-beta-1 have capacity to control the production of many components of
the extracellular matrix and enhance angiogenesis in favor of tumor growth despite of
their inhibitory effects of cell growth. However, additional research is required to
determine the exact role of TGF-beta-1 in carcinogenesis of the lung.

Å°¿öµå

TGF-beta-1; p53; Non-small cell carcinoma;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS